ESC/EASD joint guidelines on diabetes and cardiovascular diseases;ESC/EASD-leitlinien zu diabetes und kardiovaskulären erkrankungen

Herz

Volumn 34, Issue 1, 2009, Pages 21-29

  Motz, Wolfgang ^a   Dörr, Rolf ^b  

^a Klinikgruppe Dr Guth GmbH and Co KG   (Germany)

^b DRESDEN UNIVERSITY OF TECHNOLOGY   (Germany)

Author keywords

Cardiovascular diseases; Coronary artery disease equivalent; Coronary heart disease; Coronary revascularization; Diabetes mellitus; Prediabetes; Risk factors

Indexed keywords

'TAXUS'; ABCIXIMAB; ACETYLSALICYLIC ACID; ALDOSTERONE ANTAGONIST; ANGIOTENSIN RECEPTOR ANTAGONIST; ANTICOAGULANT AGENT; ATENOLOL; ATORVASTATIN; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BISOPROLOL; CARVEDILOL; CLOPIDOGREL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; EPTIFIBATIDE; FIBRINOGEN RECEPTOR ANTAGONIST; GLITAZONE DERIVATIVE; HEMOGLOBIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HYDROCHLOROTHIAZIDE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; INSULIN ASPART; LOSARTAN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; METFORMIN; METOPROLOL; TELMISARTAN; THIAZIDE DIURETIC AGENT; TIROFIBAN; UNCLASSIFIED DRUG;

ACUTE HEART INFARCTION; ANTICOAGULANT THERAPY; ANTIHYPERTENSIVE THERAPY; BARE METAL STENT; BODY MASS; CARDIOLOGIST; CARDIOVASCULAR DISEASE; CHOLESTEROL BLOOD LEVEL; COMORBIDITY; CORONARY ARTERY BYPASS SURGERY; DIABETES MELLITUS; DIABETIC NEPHROPATHY; DIABETIC RETINOPATHY; DYSLIPIDEMIA; EMBOLISM; EUROPE; FAMILY HISTORY; GLYCEMIC CONTROL; HEART ATRIUM FIBRILLATION; HEART FAILURE; HEART INFARCTION; HEART MUSCLE REVASCULARIZATION; HEART SURGERY; HEMOGLOBIN BLOOD LEVEL; HUMAN; HYPERCHOLESTEROLEMIA; HYPERTENSION; IMPAIRED GLUCOSE TOLERANCE; INTERMETHOD COMPARISON; INTERNATIONAL NORMALIZED RATIO; LIFESTYLE MODIFICATION; MEDICAL SOCIETY; METABOLIC SYNDROME X; NON INSULIN DEPENDENT DIABETES MELLITUS; ORAL GLUCOSE TOLERANCE TEST; PERCUTANEOUS CORONARY INTERVENTION; PHYSICAL ACTIVITY; PHYSICIAN; PRACTICE GUIDELINE; PRIMARY MEDICAL CARE; PRIMARY PREVENTION; PROPHYLAXIS; REVIEW; RISK MANAGEMENT; SECONDARY PREVENTION; SMOKING CESSATION; STROKE; TACHYCARDIA; THROMBOCYTE AGGREGATION; THROMBOCYTE FUNCTION; WEIGHT CONTROL; ARTICLE; CARDIOLOGY; CLINICAL PRACTICE; GERMANY; PREVENTIVE MEDICINE; STANDARD;

CARDIOLOGY; CARDIOVASCULAR DISEASES; DIABETES COMPLICATIONS; GERMANY; HUMANS; PHYSICIAN'S PRACTICE PATTERNS; PRACTICE GUIDELINES AS TOPIC; PREVENTIVE MEDICINE;

EID: 63049131344     PISSN: 03409937     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00059-009-3203-z     Document Type: Review

References (55)

1. Guidelines on diabetes, pre-diabetes, and cardiovascular diseases: executive summary. Eur Heart J 2007;28:88-136.
2. A. Norhammer A. Tenerz G. Nilsson 2002 Glucose metabolism in patients with acute myocardial infarction and no previous diagnosis of diabetes mellitus: a prospective study Lancet 359 2140 4
3. A. Stirban D. Tschoepe 2008 Cardiovascular complications in diabetes: targets and interventions Diabetes Care 31 S215 21
4. J. Berry M.E. Keebler D.K. McGuire 2004 Diabetes mellitus and cardiovascular disease. Pandora's box has been opened Herz 29 456 62
5. B. Stratmann D. Tschoepe 2005 Pathobiology and cell interactions of platelets in diabetes Diab Vasc Dis Res 2 16 23
6. S.M. Haffner S. Lehto T. Ronnemaa 1998 Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction N Engl J Med 339 229 34
7. H. Wienbergen G.A. Kai R,. f. t. Schiele ACOS Study Group 2006 Actual clinical practice of exercise testing in consecutive patients after non-ST-elevation myocardial infarction. Results of the Acute Coronary Syndomes Registry (ACOS) Eur J Cardiovasc Prev Rehabil 13 457 63
8. M. Anselmino H. Gohlke L. Mellbin 2008 Cardiovascular prevention in patients with diabetes and prediabetes Herz 33 170 7
9. M. Hanefeld W. Metzler C. Köhler 2006 Das metabolische Syndrom:.,common soil" für Diabetes und Atherosklerose. Neue Möglichkeiten für eine integrierte Therapie Herz 31 246 54
10. B. Isomaa P. Almgren T. Tuomi 2001 Cardiovascular morbidity and mortality associated with the metabolic syndrome Diabetes Care 24 683 9
11. J. Stamler O. Vaccaro JD,. f. t. Neaton Multiple Risk Factor Intervention Trial Research Group 1993 Diabetes, other risk factors, and 12-year cardiovascular mortality for men screened in the Multiple Risk Factor Intervention Trial Diabetes Care 16 434 44
12. R.C. Turner H. Millns H. f. t. Neil United Kingdom Prospective Diabetes Study Group 1998 Risk factors for coronary artery disease in non-insulin-dependent diabetes mellitus: United Kingdom Prospective Diabetes Study (UKPDS 23) BMJ 316 823 8
13. B.V. Howard D.C. Robbins M.L. Sievers 2000 LDL cholesterol as a strong risk predictor of coronary heart disease in diabetic individuals with insulin resistance and low LDL. The Strong Heart Study Arterioscler Thromb Vasc Biol 20 830 5
14. Scandinavian Simvastatin Survival Study Group 1994 Randomized trial of cholesterol-lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study Lancet 344 1383 9
15. K. Pyorala T.R. Pedersen J. Kjekshus 1997 Cholesterol lowering with simvastatin improves prognosis of diabetic patients with coronary heart disease. A subgroup analysis of the Scandinavian Simvastatin Survival Study (4S) Diabetes Care 20 614 20
16. P.S. Sever B. Dahlof NR,. f. t. Poulter ASCOT Investigators 2003 Prevention of coronary and stroke events with atorvastatin in hypertensive patients who have average or lower-than-average cholesterol concentrations, in the Anglo-Scandinavian Cardiac Outcomes Trial-Lipid Lowering Arm (ASCOT-LLA): a multicentre randomized controlled trial Lancet 361 1149 58
17. V.V. Salomaa T.E. Strandberg H. Vanhanen 1991 BMJ 302 493 6
18. A. Teuscher M. Egger J.B. Herman 1989 Diabetes and hypertension. Blood pressure in clinical diabetic patients and a control population Arch Intern Med 149 1942 5
19. T. Baba S. Neugebauer T. Watanabe 1997 Diabetic nephropathy. Its relationship to hypertension and means of pharmacological intervention Drugs 54 197 234
20. F.L. Brancati P.K. Whelton B.L. Randall 1997 Risk of end-stage renal disease in diabetes mellitus: a prospective cohort study of men screened for MRFIT: Multiple Risk Factor Intervention Trial JAMA 278 2069 74
21. G. Assman P. Cullen H. Schulte 2002 Simple scoring scheme for calculating the risk of acute coronary events based on the 10-year follow-up of the Prospective Cardiovascular Munster (PROCAM) study Circulation 105 310 5
22. A. Shehadeh T.J. Regan 1995 Cardiac consequences of diabetes mellitus Clin Cardiol 18 301 5
23. G.P. Leese J.P. Vora 1996 The management of hypertension in diabetes: with special reference to diabetic kidney disease Diabet Med 13 401 10
24. UK Prospective Diabetes Study Group. 1998 Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38 BMJ 317 703 13
25. L. Hansson A. Zanchetti S.G. Carruthers 1998 Effects of intensive blood pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) trial Lancet 351 1755 62
26. Heart Outcomes Prevention Evaluation 2000 Effects of ramipril on cardiovascular and microvascular outcomes in people with diabetes mellitus: results of the HOPE study and MICROHOPE substudy Lancet 355 253 9
27. L.H. Lindholm H. Ibsen B. Dahlöf 2002 Cardiovascular morbidity and mortality in patients with diabetes in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomized trial against atenolol Lancet 359 1004 10
28. L. Hansson L.H. Lindholm L. Niskanen 1999 Effect of angiotensin- converting-enzyme inhibition compared with conventional therapy on cardiovascular morbidity and mortality in hypertension: the Captopril Prevention Project (CAPPP) randomised trial Lancet 353 611 6
29. The ALLHAT OfficersCoordinators for the ALLHAT Collaborative Research Group. 2002 Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs. diuretic. The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT) JAMA 288 2981 97
30. P.K. Whelton J. Barzilay W.C. Cushman 2005 Clinical outcomes in antihypertensive treatment of type 2 diabetes, impaired fasting glucose concentration and normoglycaemia: Anti-Hypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT) Arch Intern Med 165 1401 9
31. B. Dahloef P. Sever N. Poulter 2005 The enhanced prevention of cardiovascular events with an amlodipine-based regimen compared with an atenolol-based regimen. The Anglo-Scandinavian Cardiac Outcomes Trial-Blood Pressure Lowering Arm (ASCOT-BPLA): a multicentre randomized controlled trial Lancet 366 895 906
32. G. De Backer E. Ambrosioni K. Borch-Johnsen 2003 Third Joint Task Force of the European and other Societies. European guidelines on cardiovascular disease prevention Eur J Cardiovasc Prev Rehabil 10 Suppl1 S1 78
33. H.C. Gerstein M.E. Miller R.P. Byington The Action to Control Cardiovascular Risk in Diabetes Study Group 2008 Effects of intensive glucose lowering in type 2 diabetes N Engl J Med 358 2545 59
34. A.H. Lauruschkat J. Ennker 2008 Diabetes mellitus in der Koronarchirurgie: Risiken und Chancen. Behandlungskonzepte für eine besonders herausfordernde Patientengruppe Herz 33 212 21
35. The BARI Investigators. 1997 Influence of diabetes on 5-year mortality and morbidity in a randomized trial comparing CABG and PTCA in patients with multivessel disease: the Bypass Angioplasty Revascularization Investigation (BARI) Circulation 96 1761 9
36. The BARI Investigators. 2000 Seven-year outcome in the Bypass Angioplasty Revascularization Investigation (BARI) by treatment and diabetic status J Am Coll Cardiol 35 1122 9
37. A. Abizaid M.A. Costa M,. t. Centemero ARTS Investigators 2001 Clinical and economic impact of diabetes mellitus on percutaneous and surgical treatment of multivessel coronary disease patients. Insights from the Arterial Revascularization Therapy Study Circulation 104 533 8
38. SYNTAX-Studie. Präsentiert auf dem ESC-Kongress, München, 08.09.2008.
39. D. Gulba R. Dechend R. Dietz 1999 Thrombolyse - neue Thrombolytika J Kardiol 6 142 53
40. G.W. Stone C.L. Grines D.A. Cox 2002 Comparison of angioplasty with stenting, with or without abciximab, in acute myocardial infarction N Engl J Med 346 957 66
41. G. Montalescot P. Barragan O. Wittenberg 2001 Platelet glycoprotein IIb/IIIa inhibition with coronary stenting for acute myocardial infarction N Engl J Med 344 1895 903
42. G. De Luca H. Suryapranata G.W. Stone 2005 Abciximab as adjunctive therapy to reperfusion in acute ST-segment elevation myocardial infarction JAMA 293 1759 65
43. E. Mahmud G. Bromberg-Marin V. Palakodeti 2008 Clinical efficacy of drug-eluting stents in diabetic patients. A meta-analysis J Am Coll Cardiol 51 2385 95
44. A. Buch A. Javaid D. Steinberg 2008 Outcomes after sirolimusand paclitaxel-eluting stent implantation in patients with insulin-treated diabetes mellitus Am J Cardiol 101 1253 8
45. D. Kumbhani A. Bavry A. Kamdar 2008 The effect of drug-eluting stents on intermediate angiographic and clinical outcomes in diabetic patients: insights from randomized clinical trials Am Heart J 155 640 7
46. S. Silber C. Herdeg 2008 Drug-eluting Stents bei Patienten mit Diabetes mellitus. Eine kritische Analyse der aktuellen Datenlage aus randomisierten Studien Herz 33 196 205
47. S. Silbers M. Borggrefe M. Böhm 1008 Medikamente freisetzende Koronarstents (DES) und Medikamente freisetzende Ballonkatheter (DEB): Aktualisierung des Positionspapiers der DGK Clin Res Cardiol 97 548 63
48. W.B. Kannel M. Hjortland W.P. Castelli 1974 Role of diabetes in congestive heart failure: the Framingham Study Am J Cardiol 34 29 34
49. L. Amato G. Paolisso F,. o. b. o. t. Cacciatore Osservatorio Geriatrico Regione Campania Group 1997 Congestive heart failure predicts the development of non-insulin-dependent diabetes mellitus in the elderly Diabetes Med 23 213 8
50. A. Mosterd B. Cost A.W. Hoes 2001 The prognosis of heart failure in the general population. The Rotterdam Study Eur Heart J 22 1318 27
51. P. De Groote N. Lamblin F. Mouquet 2004 Impact of diabetes mellitus on long-term survival in patients with congestive heart failure Eur Heart J 25 656 62
52. J. Tebbenjohanns S. Willems M. Antz 2008 Kommentar zu den.,ACC/AHA/ESC 2006 guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden c ardiac death - executive summary" Kardiologe 2 363 88
53. C.M. Albert C.U. Chae F. Grodstein 2003 Prospective study of sudden cardiac death among women in the United States Circulation 107 2096 101
54. J.D. Curb B.L. Rodriguez C.M. Burchfiel 1995 Related articles. Sudden death, impaired glucose tolerance, and diabetes in Japanese American men Circulation 91 2591 5
55. X. Jouven R.N. Lemaitre T.D. Rea 2005 Diabetes, glucose level, and risk of sudden cardiac death Eur Heart J 26 2142 7